Tema Obesity & Cardiometabolic ETF (HRTS) Holdings $29.71 +0.22 (+0.75%) As of 03:08 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsRatings Top 46 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$822.26-0.2%10.66%7,7312UNHUnitedHealth Group$481.18-1.0%5.23%7,3273Novo Nordisk A/SN/A4.39%32,1604AstraZeneca PLCN/A4.12%17,8525BBIOBridgeBio Pharma$32.59+0.8%3.95%75,6616ABTAbbott Laboratories$130.29-1.8%3.79%18,2957RHHBYRoche$43.56+3.7%3.72%58,9288VRTXVertex Pharmaceuticals$495.42+1.4%3.61%4,9969Chugai Pharmaceutical Co., Ltd.N/A3.54%45,23110MRKMerck & Co., Inc.$93.44-1.4%3.34%24,196 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. 11TMOThermo Fisher Scientific$512.94-0.2%3.09%3,87512MDTMedtronic$91.58-1.8%2.96%21,38013BSXBoston Scientific$96.42+0.9%2.93%19,08614GILDGilead Sciences$113.99-0.4%2.73%16,01015Novartis AGN/A2.73%16,52616AMGNAmgen$312.50-2.0%2.70%5,79717ABBVAbbVie$211.80-0.8%2.52%8,08218CRNXCrinetics Pharmaceuticals$35.40+3.3%2.18%43,02919DHRDanaher$205.24-0.2%1.96%6,25420BMYBristol-Myers Squibb$59.83-2.7%1.93%21,51321CYTKCytokinetics$43.99-0.9%1.93%26,64922REGNRegeneron Pharmaceuticals$689.50-4.0%1.90%1,77623EWEdwards Lifesciences$68.52+0.2%1.89%17,34324DXCMDexCom$70.76+0.7%1.83%13,67025PODDInsulet$248.38+1.2%1.76%4,33426ALNYAlnylam Pharmaceuticals$242.43+1.5%1.70%4,70327MCKMcKesson$640.93-1.9%1.56%1,64428ASNDAscendis Pharma A/S$150.31+3.2%1.49%6,39629MASIMasimo$167.67+0.7%1.35%4,76330MDGLMadrigal Pharmaceuticals$327.31-2.4%1.22%2,38831Zealand Pharma A/SN/A1.21%8,20632MREOMereo BioPharma Group$2.54+1.2%1.00%267,45933AKROAkero Therapeutics$45.85+4.6%0.90%12,34834ARWRArrowhead Pharmaceuticals$15.77+4.7%0.90%31,34335INSMInsmed$74.04+0.5%0.90%7,47636RCKTRocket Pharmaceuticals$8.80+7.2%0.88%61,76837MIRMMirum Pharmaceuticals$45.03+2.2%0.86%11,98238IONSIonis Pharmaceuticals$33.41+1.2%0.84%17,64339GPCRStructure Therapeutics$21.42+4.3%0.82%23,69040WSTWest Pharmaceutical Services$224.23-2.8%0.81%2,379Trump Orders 'National Digital Asset Stockpile' (Ad)Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…SHOW ME THE #1 CRYPTO TO OWN RIGHT NOW41VKTXViking Therapeutics$29.55+11.4%0.63%14,38042Gubra A/SN/A0.61%4,43843First American Treasury Obligations FundN/A0.50%329,98044DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.40%369,538,36145NTLAIntellia Therapeutics$9.62+3.4%0.33%19,77046US DOLLARSN/A-0.30%198,011 Geographic ExposureUnited States79.9%Denmark7.0%Japan3.2%Switzerland2.9%Currency ExposureUSD83.3%DKK7.0%JPY3.2%CHF2.9%Sector ExposureHealth Care68.0%Technology1.8%Industrials1.7%Industry ExposureBiotechnology50.0%Health Care Equipment & Supplies15.1%Pharmaceuticals2.9%Software1.8%Commercial Services & Supplies1.7%SubIndustry ExposureBiotechnology47.7%Health Care Equipment14.9%Pharmaceuticals2.9%Health Care Supplies1.9%Application Software1.8% Related Companies and Tools Related Companies Themes Lithium & Battery Metal Miners ETF Top Holdings Themes Copper Miners ETF Top Holdings Stone Ridge 2060 Inflation Protected Longevity Income ETF Top Holdings Stone Ridge 2059 Inflation-Protected Longevity Income ETF Top Holdings Ocean Park International ETF Top Holdings Themes Robotics & Automation ETF Top Holdings Themes Uranium & Nuclear ETF Top Holdings ARK 21Shares Active Ethereum Futures Strategy ETF Top Holdings Stone Ridge 2061 Inflation Protected Longevity Income ETF Top Holdings NEOS ETF Trust Kurv Yield Premi Top Holdings This page (NYSEARCA:HRTS) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts